Ocugen, Inc.
OCGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001372299
In the last 90 days, Ocugen, Inc. insiders filed 0 open-market purchases and 1 sale; 147 institutions reported holding it in 13F filings for Q2 2026, worth $222.1M in total; no superinvestor holds it.
Politicians who traded OCGN
Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.
- Trades
- 2
- Filings
- 2
- Politicians
- 1
- Buys / sells
- 1 / 1
- Estimated volume
- $40.5K
- Sum of range midpoints
| Politician | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
 Chris Jacobs House · NY | 2 | 1 / 1 | $40.5K | Nov 8, 2022 | Dec 12, 2022 |
Trades
Reported trades in Ocugen, Inc., newest filings first.
| Politician | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
Chris Jacobs House · NY | OCGNOcugen, Inc. | Sell | Self | Nov 8, 2022 | Dec 12, 2022 | 34 days | $1K-$15K | Filing |
Chris Jacobs House · NY | OCGNOcugen, Inc. | Buy | Self | Jun 16, 2022 | Jul 28, 2022 | 42 days | $15K-$50K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.